Silk sericin-based hydrogel, methods and uses thereof

Ana Leite Oliveira; Sara Baptista da Silva; Sandra Cristina Ferreira Borges; Paulo Alves

Silk sericin-based hydrogel, methods and uses thereof

Ana Leite Oliveira (Inventor)
, Sara Baptista da Silva (Inventor)
, Sandra Cristina Ferreira Borges (Inventor)
, Paulo Alves (Inventor)

Research output: Patent

8 Downloads

Abstract

The present disclosure relates to a novel sericin-based hydrogel for an improved treatment of wound healing, ischemic diseases or cardiovascular diseases, namely chronic wound healing, in particular diabetic wound.
The technology consists in an in-situ forming silk sericin-based hydrogel healing bio a novel wound material.

Original language	English
Patent number	US11110206
IPC	A61L27/22,A61L27/52,A61L27/54,A61L15/44,A61L15/48,A61L15/58,A61L15/60,A61L15/64,A61L26/00,C08J3/075
Priority date	12/07/16
Filing date	12/07/17
Publication status	Accepted/In press - 7 Sept 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

Cite this

@misc{d56050e20dd64d73ae3abe83d0b9dc0a,

title = "Silk sericin-based hydrogel, methods and uses thereof",

abstract = "The present disclosure relates to a novel sericin-based hydrogel for an improved treatment of wound healing, ischemic diseases or cardiovascular diseases, namely chronic wound healing, in particular diabetic wound. The technology consists in an in-situ forming silk sericin-based hydrogel healing bio a novel wound material. ",

author = "Oliveira, \{Ana Leite\} and Silva, \{Sara Baptista da\} and Borges, \{Sandra Cristina Ferreira\} and Paulo Alves",

year = "2021",

month = sep,

day = "7",

language = "English",

publisher = "United States Patent and Trademark Office",

address = "United States",

type = "Patent",

note = "US11110206; A61L27/22,A61L27/52,A61L27/54,A61L15/44,A61L15/48,A61L15/58,A61L15/60,A61L15/64,A61L26/00,C08J3/075",

}

TY - PAT

T1 - Silk sericin-based hydrogel, methods and uses thereof

AU - Oliveira, Ana Leite

AU - Silva, Sara Baptista da

AU - Borges, Sandra Cristina Ferreira

AU - Alves, Paulo

PY - 2021/9/7

Y1 - 2021/9/7

N2 - The present disclosure relates to a novel sericin-based hydrogel for an improved treatment of wound healing, ischemic diseases or cardiovascular diseases, namely chronic wound healing, in particular diabetic wound. The technology consists in an in-situ forming silk sericin-based hydrogel healing bio a novel wound material.

AB - The present disclosure relates to a novel sericin-based hydrogel for an improved treatment of wound healing, ischemic diseases or cardiovascular diseases, namely chronic wound healing, in particular diabetic wound. The technology consists in an in-situ forming silk sericin-based hydrogel healing bio a novel wound material.

UR - https://worldwide.espacenet.com/patent/search/family/059564217/publication/US11110206B2?q=pn%3DUS11110206B2

M3 - Patent

M1 - US11110206

Y2 - 2017/07/12

PB - United States Patent and Trademark Office

ER -

Silk sericin-based hydrogel, methods and uses thereof

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Silk sericin-based hydrogel, methods and uses thereof

Cite this